Related Experiment Videos

A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon

L G Gürtler1, P H Hauser, J Eberle

  • 1Max von Pettenkofer Institute, University of Munich, Germany.

Journal of Virology
|March 1, 1994
PubMed

Insights

A novel human immunodeficiency virus type 1 (HIV-1) subtype, MVP-5180, was identified in Cameroon. This divergent HIV-1 strain, subtype O, has unique genetic and serological characteristics, impacting HIV evolution and vaccine development.

Area of Science:

  • Virology
  • Immunology
  • Genetics

Background:

  • Human immunodeficiency virus type 1 (HIV-1) exhibits genetic diversity, with various subtypes circulating globally.
  • Understanding the genetic and antigenic properties of different HIV-1 subtypes is crucial for effective diagnostics and vaccine design.
  • Previous studies have identified distinct HIV-1 subtypes, but novel strains continue to emerge, particularly in certain geographic regions.

Purpose of the Study:

  • To characterize a newly isolated human immunodeficiency virus type 1 (HIV-1) subtype, designated MVP-5180, from a patient in Cameroon.
  • To investigate the genetic relatedness, serological reactivity, and unique features of MVP-5180 compared to other known HIV-1 and HIV-2 strains.
  • To assess the prevalence and significance of this new subtype in the Cameroonian HIV-1-infected population.

Main Methods:

  • Isolation and propagation of MVP-5180 in human T-cell and monocytic cell lines.
  • Polymerase chain reaction (PCR) amplification using conventional and specific primers for HIV-1 genes (env, gag, pol).
  • Serological analysis using immunoblots with anti-HIV-1 sera from different countries.
  • DNA sequencing and phylogenetic analysis of MVP-5180, including V3 loop sequencing, to determine genetic relationships.

Main Results:

  • MVP-5180 DNA showed limited amplification with conventional primers but was detectable with specific primers.
  • Serological assays revealed differential reactivity of MVP-5180 Env proteins with sera from various regions, with strong reactions from Cameroonian sera.
  • Sequence analysis indicated MVP-5180 is a distinct HIV-1 subtype (subtype O) with significant genetic divergence from other HIV-1 and HIV-2 strains, particularly in the env gene and V3 loop.
  • MVP-5180 was identified in 8% of HIV-1-infected Cameroonians by serology and 7% by PCR.

Conclusions:

  • MVP-5180 represents a new, highly divergent subtype (subtype O) of HIV-1, distinct from previously characterized strains.
  • The unique genetic and serological profile of MVP-5180 highlights the complex evolutionary dynamics of HIV.
  • Characterization of MVP-5180 is essential for understanding primate lentivirus evolution and for developing broadly effective HIV vaccines and diagnostics.

Related Concept Videos